Maternal influenza infection during pregnancy is associated with increased risk of morbidity and mortality. However, the link between the anti-influenza immune responses and healthrelated risks during infection is not well understood. We have analyzed memory T and NK cell mediated immunity (CMI) responses in pandemic influenza A(H1N1)pdm09 (pdm09) virus infected non-vaccinated pregnant women participating in the Norwegian Influenza Pregnancy Cohort (NorFlu). The cohort includes information on immunization, self-reported health and disease status, and biological samples (plasma and PBMC). Infected cases (N = 75) were defined by having a serum hemagglutination inhibition (HI) titer > = 20 to influenza pdm09 virus at the time of delivery, while controls (N = 75) were randomly selected among non-infected pregnant women (HI titer <10). In ELISpot assays cases had higher frequencies of IFNγ + CD8 + T cells responding to pdm09 virus or conserved CD8 T cell-restricted 
Introduction
During the 2009 influenza pandemic, pregnant women had an increased risk of severe influenza illness and adverse pregnancy outcomes [1] [2] [3] , and 12% of pregnancy-related deaths were attributed to pandemic infection [4] . The mechanisms behind influenza infection-related mortality and morbidity in pregnancy are still poorly understood, however it is speculated that immune modulation required for fetal tolerance may be one of the major contributing factors [5] [6] [7] . Murine models suggest that increased mortality and morbidity may be due to either a deficiency in cellular immunity or to a hyper-reactive immune response to inflammatory cytokines and chemokines that govern cellular infiltration and exacerbation of symptoms [8, 9] . In humans, the frequencies of monocytes and dendritic cells were increased whereas natural killer (NK) and T cells frequencies were decreased [10] . NK and T cells from pregnant women had reduced production of interferon (IFN)-γ and macrophage inflammatory protein (MIP)-1β [10, 11] . Recently, CD8
+ effector cells and T regulatory cells (Tregs) at the fetal-maternal interface were implicated as modulators of fetal-immune tolerance and antiviral immunity [12] [13] [14] . Due to repeated exposure to circulating influenza strains in adults cellular immunity is dominated by memory T cell responses. In the case of the 2009 pandemic, the new influenza H1N1 strain was a result of reassortment between swine, human and avian influenza A strains [15] . This strain contained several novel epitopes able to elicit naive CD4 + and CD8 + T cell responses with potentially different dynamics to those existing from pre-established (heterosubtypic) memory responses against the conserved epitopes. Heterosubtypic immunity is mainly mediated by cross-reactive cytotoxic CD8 + T cells [16] [17] [18] , and pre-existing influenzaspecific CD4 + and CD8 + T cells effectively cross-reacted to the newly emerged influenza A (H1N1)pdm09 virus [19] [20] [21] [22] [23] .
We analyzed memory cellular immune responses in relation to influenza-like illness (ILI) symptoms after pandemic influenza A(H1N1)pdm09 virus infection during pregnancy. Our results showed that virus specific and functionally distinct T and NK cell populations may serve as cellular memory-immune correlates of favorable clinical outcomes of pandemic influenza disease. A nested case-control study of non-vaccinated pregnant women included infected cases and non-infected controls during the pandemic peak in Norway (1.10.2009.-31.12.2009 .) (S1 Table) . Cases (N = 75) were defined by having a serum hemagglutination inhibition (HI) titer > = 20 to A(H1N1)pdm09 virus at the time of delivery. Controls (N = 75) were randomly selected among non-infected pregnant women with an HI titer <10 at delivery. Pre-existing protective HI titers to the influenza A(H1N1)pdm09 virus were low in the Norwegian population prior to the pandemic, including women of fertile age [24] .
Materials and methods

Study participants and design
Outcomes and symptom score
Cases were further categorized based on self-reported questionnaires as 1) symptomaticreporting influenza-like illness (ILI) symptoms during the pandemic peak (October-December 2009): fever and cough or fever and sore throat, or 2) asymptomatic-reporting no ILI symptoms. Further, a symptom score was designed by totaling the weight for each of the canonical ILI symptoms: fever, cough, sore throat, rhinitis, headache, and myalgia, with a weight of 1, 4 or 6, if the reported duration of symptoms was 0-2, 3-5 or more than 5 days, respectively. Self-report of many symptoms, more severe illness and longer duration of illness were associated with higher HI titers (p<0.05 for all comparisons, manuscript in preparation).
Pandemic virus and epitope libraries
In all ELISpot and flow cytometry assays a H 2 O 2 inactivated A/California/07/2009(H1N1) pdm09 (pdm09) virus was used at 75 hemagglutination units (HAU) for stimulation of PBMC [25] . In addition, a total of seven influenza A epitope libraries were used as previously described [26] . In brief, conserved influenza A epitopes were divided in four universal influenza A peptide libraries according to MHC class I and II restriction (uCD8 and uCD4, respectively). The libraries were divided according to epitope origin: 1) external viral proteinsuCD8e and uCD4e, and 2) internal viral proteins-uCD8i and uCD4i. Peptides unique for the pandemic A(H1N1)pdm09 virus were similarly grouped in three libraries: pCD4e, pCD8i and pCD4i (pCD8e library did not include unique peptides; more details in [26] ).
Ex vivo enzyme-linked IFNγ/Granzyme B immunospot assay (ELISpot)
ELISpot assays were performed as previously described [26] , with additional information provided in Supplementary Materials and Methods (S1 and S2 Figs, S1 and S2 Files).
Flow cytometry assays
Flow cytometry assays, and gating strategies, were performed as previously described [26] [27] [28] , with additional information provided in Supplementary Materials and Methods (S7 and S8 Figs, S2 Table, S1 and S2 Files). Cells were analyzed on a BD LSRII flow cytometer using FACS Diva and FlowJo (TreeStar) software. Cells were gated according to forward-and side-scatter plots, and 40,000 CD4 + T cells, or 25,000 CD3 -cells, were acquired. All functional values are presented as a fold change over a negative control, assuming synergistic rather than an additive effect [29] .
Statistical analyses
The frequencies of antigen-specific T cells in ELISpot assays between exposure groups were compared using Wilcoxon rank-sum test. The Kruskal-Wallis test followed by Dunn's 'posthoc' test was used to analyze differences in antigen-specific T cells frequency fold change among the three exposure groups in flow cytometry experiments. Presence of individual ILI symptom and the frequency of IFNγ and Granzyme B producing PBMC, and frequency of T and NK cells analyzed by flow cytometry were correlated using point biserial correlation (i.e. to correlate a dichotomous and a continuous variable). Total symptom score and cell frequencies were analyzed by Spearman rank correlation (i.e. to correlate two continuous variables).
Results
Frequency of IFNγ-secreting CD8 + T cells was correlated with asymptomatic infection
Cases had a higher median frequency of IFNγ-secreting cells compared to controls after stimulation with the whole inactivated pdm09 virus (p = 0.0169), or the uCD8i epitope library (p = 0.0037), but not after stimulation with the uCD4i epitope library (Fig 1A, 1B and 1C) . Further analysis of cases, based on reported illness symptoms, showed a higher frequency of IFNγ-secreting cells in cases reporting no symptoms (N = 37) compared to those who experienced ILI symptoms (N = 38) (p = 0.0287), after stimulation with the uCD8i epitope library (Fig 1F) . The frequency of this cell population was inversely correlated with the ILI symptoms (rho = -0.2303, p = 0.0468), suggesting a protective role of these cells against the symptomatic pdm09 infection. The levels of anti-pdm09 virus antibodies were comparable between symptomatic and asymptomatic cases (p = 0.5180, data not shown).
In contrast, in infected symptomatic women (N = 38), the total symptom score during ILI had modest positive correlation with the frequency of IFNγ secreting cells after stimulation with universal internal CD4 epitopes (uCD4i, rho = 0.3173, p = 0.0491) (Fig 1E) . Collectively, our results suggest somewhat opposing roles of IFNγ-secreting T cells: protective effect against the symptomatic illness mediated by cells responding to the universal CD8 internal influenza (Fig 2A and 2C) . The frequency of + T cells specific for uCD8i epitopes were higher in asymptomatic cases compared to symptomatic cases (~3.5, 2, 2, and >4 fold, respectively) ( Fig 3C) . Stimulation with HLA class I restricted CMV peptides did not induce significant changes in comparable CD8 + T cell populations (Fig 3D) , further strengthening the observation that the effector CD8 + T cell responses were influenza A specific with a potential to provide heterosubtypic immunity since the uCD8i peptide epitope library represents a collection of conserved epitopes present in influenza A strains spanning the period from 1934 to 2009 [26] .
Different NK cell populations were associated with ILI symptoms
The cell frequencies of the total NK and CD107a + NK cells were comparable among three groups of women (Fig 4A and 4B) were positively correlated, suggesting a possible mechanism of reinforcing the inflammatory loop between innate and adaptive CMI responses. The overall differences in cellular correlations of the CMI response networks between the three groups of pregnant women were statistically significant (p<0.0001, S5 Fig) , indicating an association between altered CMI responses and disease severity in pregnancy.
Discussion
We analyzed the relationship between T and NK cell-mediated immunity and disease severity in pregnant women infected with influenza A(H1N1)pdm09 virus during the 2009 pandemic in Norway. Influenza infected women without ILI symptoms had a higher magnitude of IFNγ producing CD8 + T cells, compared to those reporting symptoms, as measured in ELISpot assays after stimulation with the pdm09 virus or peptides representing conserved CD8 + T cell epitopes (uCD8i). These antigen-specific CD8 + T cells are of particular interest due to their ability to provide cross-protective immunity against a range of influenza viruses [20, 21, 30, 31] , and may provide the basis for universal influenza vaccine development [16, 32] . The inverse correlation observed between reported symptoms and frequency of IFNγ-secreting T cells indicates a putative protective effect of this cell population against symptomatic pandemic influenza illness during pregnancy. A similar observation has been reported previously: higher frequencies of pre-existing T cells specific for influenza A CD8 epitopes were found in individuals who reported mild ILI symptoms [21] . Nevertheless, it must be noted that the samples in our study were collected at the time of delivery, which means that the average time interval between exposure to pandemic influenza A(H1N1)pdm09 virus and the collection of the blood samples was 7.5 months. However, due to the fact that the average human is exposed on multiple occasions to influenza infection during their lifetime, and that our universal CD8 + T cell epitope library contains the most conserved influenza A epitopes, it is reasonable to assume that some, if not most, of the IFNγ + CD8 + T cells, responding to such epitopes, were present before the pandemic and thus may have provided cross-protective immunity against the 2009 pandemic strain. We further examined the association between different memory T cell subtypes and disease severity after exposure to the A(H1N1)pdm09 virus. Our results suggest that the CD95 ) with cytotoxic potential against conserved CD4 epitopes in a human challenge study [23] . In contrast, Sridhar et al. identified pre-existing IFNγ + CD8 + Temra cells, specific for conserved influenza A viral epitopes, as cellular immune correlates of protection against community acquired symptomatic pandemic influenza [21] . Abundant expression of the CD95 marker on naive memory T cells was recently described on so-called memory stem T cells (T SCM ), which were characterized by enhanced self-renewal and multipotency, increased proliferative capabilities and rapid acquisition of effector functions after antigen stimulation [33] . We observed increased frequencies of CD95 Strengths of our study are reflected in the uniqueness of the biobank that contains plasma, PBMC, DNA and RNA from women pregnant during the pandemic peak in Norway. Also, extensive data collection about the immunization, health and disease status through national health registries and questionnaires allows analyzing associations between self-reported ILI symptoms and CMI. However, limitations are reflected in an inability to establish baseline responses due to unpredictable occurrence of the pandemic influenza and the timing of pregnancy and sample collection; furthermore the study had limited samples available. Samples were from the peripheral blood, thus the overall picture of cellular immune effector functions and memory does not reflect tissue-specific immunity (e.g. upper airways or lungs). Finally, most women were exposed during the first trimester of pregnancy whereas blood samples were collected at birth. The observed cell frequencies of antigen specific CD4 and CD8 T cells and NK cells could have been affected by the hormonal status at labor, as it was noted previously that a rise in progesterone and estradiol levels could negatively influence cell frequencies of adaptive immunity [5, 6] . Therefore it is of great importance to continue efforts to analyze CMI in different trimesters of pregnancy specifically in the acute phase of influenza A infection.
Influenza infection in pregnancy is a complex, challenging and clinically important problem. In a community acquired infection setting, we observed qualitatively and quantitatively different CMI responses against the pandemic A(H1N1)pdm09 virus in symptomatic and asymptomatic pregnant women, which are probably major determinants of illness progression and severity. Furthermore, we have identified several antigen-specific T cell populations which potentially can be used as cellular immune correlates of cross-protection against different influenza A viruses during pregnancy. Understanding interactions between various immune cell types (e.g. T and NK cells) of the maternal immune system and the virus, and influence of immune and hormonal signals from maternal-fetal barrier, both systemically and locally, may lead to improved disease management and prevention strategies. Furthermore, our data expand the growing immunological evidence-based impetus for the design of universal influenza vaccines to induce cross-reactive T cells that could confer protection against emerging influenza viruses. 
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